Consumption of Non-Prescribed Drugs in Portugal During the Pandemic in 2021

Int J Public Health. 2023 Jul 20:68:1606021. doi: 10.3389/ijph.2023.1606021. eCollection 2023.

Abstract

Objectives: Portugal liberalised the over-the-counter drugs market in 2005 and provides universal healthcare coverage in a mainly Beveridge-type health system. However, the COVID-19 pandemic has forced healthcare to change how services were delivered, especially increasing remote consultations in primary care. This analysis aims to find the drivers for taking non-prescribed drugs during the pandemic in Portugal. Specifically, it seeks to understand the role of taking prescribed drugs and attending remote medical appointments in the self-medication decision. Methods: In this observational study, we used data collected during the pandemic in Centre Region of Portugal and estimated logistic regression for the whole sample and stratified by sex. Results: The main findings show that people taking prescribed medications and attending a remote consultation are more likely to take non-prescribed drugs. Also, reporting unmet healthcare needs seems to motivate people to choose self-medication. Conclusion: Policy implications are pointed out concerning the health risks raised from self-medication, the role of the pharmacist advising non-prescribed drugs, and the related health risks arising from unmet healthcare needs.

Keywords: COVID-19; Portugal; behind-the-counter drugs; nonprescription drugs; social determinants.

Publication types

  • Observational Study

MeSH terms

  • COVID-19* / epidemiology
  • Humans
  • Nonprescription Drugs / therapeutic use
  • Pandemics*
  • Portugal / epidemiology
  • Self Medication

Substances

  • Nonprescription Drugs